APO Research
Talk to an analyst

APO RESEARCH · REPORT

Penicillin and Streptomycin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Penicillin and Streptomycin Industry Growth and Trends Forecast to 2032

22 December 2025103 pages

Choose your research edition.

Industry ResearchPenicillin and Streptomycin Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Penicillin and Streptomycin Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Penicillin and Streptomycin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Penicillin and Streptomycin Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Penicillin and Streptomycin Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Penicillin and Streptomycin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Penicillin and Streptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Penicillin and Streptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Penicillin and Streptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Penicillin and Streptomycin include Takeda Pharmaceutical, Johnson & Johnson, Merck, Eli Lilly, GlaxoSmithKline, Toyama Chemical, MiddleBrook Pharmaceuticals, Gilead Sciences and Astra Zeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Penicillin and Streptomycin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Penicillin and Streptomycin market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Penicillin and Streptomycin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Penicillin and Streptomycin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Penicillin and Streptomycin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Penicillin and Streptomycin Market by Company

Takeda Pharmaceutical

Johnson & Johnson

Merck

Eli Lilly

GlaxoSmithKline

Toyama Chemical

MiddleBrook Pharmaceuticals

Gilead Sciences

Astra Zeneca

Astellas Pharma

Penicillin and Streptomycin Segment by Type

Penicillin

Streptomycin

Penicillin and Streptomycin Segment by Application

Throat Infections

Meningitis

Tuberculosis Treatment

Penicillin and Streptomycin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Penicillin and Streptomycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Penicillin and Streptomycin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Penicillin and Streptomycin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Penicillin and Streptomycin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Penicillin and Streptomycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Penicillin Table 2. Major Company of Streptomycin Table 3. Global Penicillin and Streptomycin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Penicillin and Streptomycin Sales by Type (2021-2026) & (k units) Table 5. Global Penicillin and Streptomycin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Penicillin and Streptomycin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Penicillin and Streptomycin Sales Market Share in Value by Type (2021-2026) Table 8. Global Penicillin and Streptomycin Price by Type (2021-2026) & (US$/unit) Table 9. Global Penicillin and Streptomycin Sales by Type (2027-2032) & (k units) Table 10. Global Penicillin and Streptomycin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Penicillin and Streptomycin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Penicillin and Streptomycin Sales Market Share in Value by Type (2027-2032) Table 13. Global Penicillin and Streptomycin Price by Type (2027-2032) & (US$/unit) Table 14. North America Penicillin and Streptomycin Sales by Type (2021-2026) & (k units) Table 15. North America Penicillin and Streptomycin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Penicillin and Streptomycin Sales by Type (2021-2026) & (k units) Table 17. Europe Penicillin and Streptomycin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Penicillin and Streptomycin Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Penicillin and Streptomycin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Penicillin and Streptomycin Sales by Type (2021-2026) & (k units) Table 21. Latin America Penicillin and Streptomycin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Penicillin and Streptomycin Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Penicillin and Streptomycin Sales by Type (2021-2026) & (US$ Million) Table 24. Penicillin and Streptomycin Industry Trends Table 25. Penicillin and Streptomycin Industry Drivers Table 26. Penicillin and Streptomycin Industry Opportunities and Challenges Table 27. Penicillin and Streptomycin Industry Restraints Table 28. Global Penicillin and Streptomycin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Penicillin and Streptomycin Revenue Market Share by Company (2021-2026) Table 30. Global Penicillin and Streptomycin Sales by Company (2021-2026) & (k units) Table 31. Global Penicillin and Streptomycin Sales Share by Company (2021-2026) Table 32. Global Penicillin and Streptomycin Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Penicillin and Streptomycin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Penicillin and Streptomycin Major Company Production Sites and Headquarters Table 35. Global Penicillin and Streptomycin Company, Product Type & Application Table 36. Global Penicillin and Streptomycin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Penicillin and Streptomycin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Penicillin and Streptomycin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Penicillin and Streptomycin Sales by Region (2021-2026) & (k units) Table 41. Global Penicillin and Streptomycin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Penicillin and Streptomycin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Penicillin and Streptomycin Sales Market Share in Value by Region (2021-2026) Table 44. Global Penicillin and Streptomycin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Penicillin and Streptomycin Sales by Region (2027-2032) & (k units) Table 46. Global Penicillin and Streptomycin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Penicillin and Streptomycin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Penicillin and Streptomycin Sales Market Share in Value by Region (2027-2032) Table 49. Global Penicillin and Streptomycin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Penicillin and Streptomycin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Penicillin and Streptomycin Sales by Application (2021-2026) & (k units) Table 52. Global Penicillin and Streptomycin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Penicillin and Streptomycin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Penicillin and Streptomycin Sales Market Share in Value by Application (2021-2026) Table 55. Global Penicillin and Streptomycin Price by Application (2021-2026) & (US$/unit) Table 56. Global Penicillin and Streptomycin Sales by Application (2027-2032) & (k units) Table 57. Global Penicillin and Streptomycin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Penicillin and Streptomycin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Penicillin and Streptomycin Sales Market Share in Value by Application (2027-2032) Table 60. Global Penicillin and Streptomycin Price by Application (2027-2032) & (US$/unit) Table 61. North America Penicillin and Streptomycin Sales by Application (2021-2026) & (k units) Table 62. North America Penicillin and Streptomycin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Penicillin and Streptomycin Sales by Application (2021-2026) & (k units) Table 64. Europe Penicillin and Streptomycin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Penicillin and Streptomycin Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Penicillin and Streptomycin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Penicillin and Streptomycin Sales by Application (2021-2026) & (k units) Table 68. Latin America Penicillin and Streptomycin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Penicillin and Streptomycin Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Penicillin and Streptomycin Sales by Application (2021-2026) & (US$ Million) Table 71. Takeda Pharmaceutical Company Information Table 72. Takeda Pharmaceutical Business Overview Table 73. Takeda Pharmaceutical Penicillin and Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Takeda Pharmaceutical Penicillin and Streptomycin Product Portfolio Table 75. Takeda Pharmaceutical Recent Development Table 76. Johnson & Johnson Company Information Table 77. Johnson & Johnson Business Overview Table 78. Johnson & Johnson Penicillin and Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Johnson & Johnson Penicillin and Streptomycin Product Portfolio Table 80. Johnson & Johnson Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Penicillin and Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Merck Penicillin and Streptomycin Product Portfolio Table 85. Merck Recent Development Table 86. Eli Lilly Company Information Table 87. Eli Lilly Business Overview Table 88. Eli Lilly Penicillin and Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Eli Lilly Penicillin and Streptomycin Product Portfolio Table 90. Eli Lilly Recent Development Table 91. GlaxoSmithKline Company Information Table 92. GlaxoSmithKline Business Overview Table 93. GlaxoSmithKline Penicillin and Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. GlaxoSmithKline Penicillin and Streptomycin Product Portfolio Table 95. GlaxoSmithKline Recent Development Table 96. Toyama Chemical Company Information Table 97. Toyama Chemical Business Overview Table 98. Toyama Chemical Penicillin and Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Toyama Chemical Penicillin and Streptomycin Product Portfolio Table 100. Toyama Chemical Recent Development Table 101. MiddleBrook Pharmaceuticals Company Information Table 102. MiddleBrook Pharmaceuticals Business Overview Table 103. MiddleBrook Pharmaceuticals Penicillin and Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. MiddleBrook Pharmaceuticals Penicillin and Streptomycin Product Portfolio Table 105. MiddleBrook Pharmaceuticals Recent Development Table 106. Gilead Sciences Company Information Table 107. Gilead Sciences Business Overview Table 108. Gilead Sciences Penicillin and Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Gilead Sciences Penicillin and Streptomycin Product Portfolio Table 110. Gilead Sciences Recent Development Table 111. Astra Zeneca Company Information Table 112. Astra Zeneca Business Overview Table 113. Astra Zeneca Penicillin and Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Astra Zeneca Penicillin and Streptomycin Product Portfolio Table 115. Astra Zeneca Recent Development Table 116. Astellas Pharma Company Information Table 117. Astellas Pharma Business Overview Table 118. Astellas Pharma Penicillin and Streptomycin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Astellas Pharma Penicillin and Streptomycin Product Portfolio Table 120. Astellas Pharma Recent Development Table 121. North America Penicillin and Streptomycin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. North America Penicillin and Streptomycin Sales by Country (2021-2026) & (k units) Table 123. North America Penicillin and Streptomycin Sales Market Share by Country (2021-2026) Table 124. North America Penicillin and Streptomycin Sales Forecast by Country (2027-2032) & (k units) Table 125. North America Penicillin and Streptomycin Sales Market Share Forecast by Country (2027-2032) Table 126. North America Penicillin and Streptomycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Penicillin and Streptomycin Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Penicillin and Streptomycin Market Share by Country (2021-2026) Table 129. North America Penicillin and Streptomycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Penicillin and Streptomycin Market Share Forecast by Country (2027-2032) Table 131. Europe Penicillin and Streptomycin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Europe Penicillin and Streptomycin Sales by Country (2021-2026) & (k units) Table 133. Europe Penicillin and Streptomycin Sales Market Share by Country (2021-2026) Table 134. Europe Penicillin and Streptomycin Sales Forecast by Country (2027-2032) & (k units) Table 135. Europe Penicillin and Streptomycin Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Penicillin and Streptomycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Penicillin and Streptomycin Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Penicillin and Streptomycin Market Share by Country (2021-2026) Table 139. Europe Penicillin and Streptomycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Penicillin and Streptomycin Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Penicillin and Streptomycin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Penicillin and Streptomycin Sales by Country (2021-2026) & (k units) Table 143. Asia-Pacific Penicillin and Streptomycin Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Penicillin and Streptomycin Sales Forecast by Country (2027-2032) & (k units) Table 145. Asia-Pacific Penicillin and Streptomycin Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Penicillin and Streptomycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Penicillin and Streptomycin Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Penicillin and Streptomycin Market Share by Country (2021-2026) Table 149. Asia-Pacific Penicillin and Streptomycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Penicillin and Streptomycin Market Share Forecast by Country (2027-2032) Table 151. Latin America Penicillin and Streptomycin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Latin America Penicillin and Streptomycin Sales by Country (2021-2026) & (k units) Table 153. Latin America Penicillin and Streptomycin Sales Market Share by Country (2021-2026) Table 154. Latin America Penicillin and Streptomycin Sales Forecast by Country (2027-2032) & (k units) Table 155. Latin America Penicillin and Streptomycin Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Penicillin and Streptomycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Penicillin and Streptomycin Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Penicillin and Streptomycin Market Share by Country (2021-2026) Table 159. Latin America Penicillin and Streptomycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Penicillin and Streptomycin Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Penicillin and Streptomycin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Penicillin and Streptomycin Sales by Country (2021-2026) & (k units) Table 163. Middle East and Africa Penicillin and Streptomycin Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Penicillin and Streptomycin Sales Forecast by Country (2027-2032) & (k units) Table 165. Middle East and Africa Penicillin and Streptomycin Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Penicillin and Streptomycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Penicillin and Streptomycin Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Penicillin and Streptomycin Market Share by Country (2021-2026) Table 169. Middle East and Africa Penicillin and Streptomycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Penicillin and Streptomycin Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Penicillin and Streptomycin Distributors List Table 174. Penicillin and Streptomycin Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Penicillin and Streptomycin Image Figure 2. Global Penicillin and Streptomycin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Penicillin and Streptomycin Market Size (2021-2032) & (US$ Million) Figure 4. Global Penicillin and Streptomycin Sales (2021-2032) & (k units) Figure 5. Penicillin Image Figure 6. Global Penicillin Sales YoY Growth (2021-2032) & (k units) Figure 7. Streptomycin Image Figure 8. Global Streptomycin Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Penicillin and Streptomycin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Penicillin and Streptomycin Market Share by Type 2025 VS 2032 Figure 11. North America Penicillin and Streptomycin Sales Market Share in Volume by Type in 2025 Figure 12. North America Penicillin and Streptomycin Sales Market Share in Value by Type in 2025 Figure 13. Europe Penicillin and Streptomycin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Penicillin and Streptomycin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Penicillin and Streptomycin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Penicillin and Streptomycin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Penicillin and Streptomycin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Penicillin and Streptomycin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Penicillin and Streptomycin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Penicillin and Streptomycin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Penicillin and Streptomycin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Throat Infections Image Figure 24. Global Throat Infections Sales YoY Growth (2021-2032) & (k units) Figure 25. Meningitis Image Figure 26. Global Meningitis Sales YoY Growth (2021-2032) & (k units) Figure 27. Tuberculosis Treatment Image Figure 28. Global Tuberculosis Treatment Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Penicillin and Streptomycin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Penicillin and Streptomycin Market Share by Application 2025 VS 2032 Figure 31. North America Penicillin and Streptomycin Sales Market Share in Volume by Application in 2025 Figure 32. North America Penicillin and Streptomycin Sales Market Share in Value by Application in 2025 Figure 33. Europe Penicillin and Streptomycin Sales Market Share in Volume by Application in 2025 Figure 34. Europe Penicillin and Streptomycin Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Penicillin and Streptomycin Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Penicillin and Streptomycin Sales Market Share in Value by Application in 2025 Figure 37. Latin America Penicillin and Streptomycin Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Penicillin and Streptomycin Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Penicillin and Streptomycin Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Penicillin and Streptomycin Sales Market Share in Value by Application in 2025 Figure 41. North America Penicillin and Streptomycin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Penicillin and Streptomycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Penicillin and Streptomycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Penicillin and Streptomycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Penicillin and Streptomycin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Penicillin and Streptomycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Penicillin and Streptomycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Penicillin and Streptomycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Penicillin and Streptomycin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Penicillin and Streptomycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Penicillin and Streptomycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Penicillin and Streptomycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Penicillin and Streptomycin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Penicillin and Streptomycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Penicillin and Streptomycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Penicillin and Streptomycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Penicillin and Streptomycin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Penicillin and Streptomycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Penicillin and Streptomycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Penicillin and Streptomycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Penicillin and Streptomycin Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Penicillin and Streptomycin Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Penicillin
  • Streptomycin
Applications
  • Throat Infections
  • Meningitis
  • Tuberculosis Treatment
Companies covered
  • Takeda Pharmaceutical
  • Johnson & Johnson
  • Merck
  • Eli Lilly
  • GlaxoSmithKline
  • Toyama Chemical
  • MiddleBrook Pharmaceuticals
  • Gilead Sciences
  • Astra Zeneca
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Penicillin and Streptomycin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Penicillin and Streptomycin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Penicillin and Streptomycin Market by Type
  6. 1.3.1 Penicillin
  7. 1.3.2 Streptomycin
  8. 1.4 Global Penicillin and Streptomycin Market Size by Type
  9. 1.4.1 Global Penicillin and Streptomycin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Penicillin and Streptomycin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Penicillin and Streptomycin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Penicillin and Streptomycin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Penicillin and Streptomycin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Penicillin and Streptomycin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Penicillin and Streptomycin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Penicillin and Streptomycin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Penicillin and Streptomycin Industry Trends
  2. 2.2 Penicillin and Streptomycin Industry Drivers
  3. 2.3 Penicillin and Streptomycin Industry Opportunities and Challenges
  4. 2.4 Penicillin and Streptomycin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Penicillin and Streptomycin Revenue (2021-2026)
  2. 3.2 Global Top Players by Penicillin and Streptomycin Sales (2021-2026)
  3. 3.3 Global Top Players by Penicillin and Streptomycin Price (2021-2026)
  4. 3.4 Global Penicillin and Streptomycin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Penicillin and Streptomycin Major Company Production Sites & Headquarters
  6. 3.6 Global Penicillin and Streptomycin Company, Product Type & Application
  7. 3.7 Global Penicillin and Streptomycin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Penicillin and Streptomycin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Penicillin and Streptomycin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Penicillin and Streptomycin Tier 1, Tier 2, and Tier 3
4 Penicillin and Streptomycin Regional Status and Outlook
  1. 4.1 Global Penicillin and Streptomycin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Penicillin and Streptomycin Historic Market Size by Region
  3. 4.2.1 Global Penicillin and Streptomycin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Penicillin and Streptomycin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Penicillin and Streptomycin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Penicillin and Streptomycin Forecasted Market Size by Region
  7. 4.3.1 Global Penicillin and Streptomycin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Penicillin and Streptomycin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Penicillin and Streptomycin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Penicillin and Streptomycin by Application
  1. 5.1 Penicillin and Streptomycin Market by Application
  2. 5.1.1 Throat Infections
  3. 5.1.2 Meningitis
  4. 5.1.3 Tuberculosis Treatment
  5. 5.2 Global Penicillin and Streptomycin Market Size by Application
  6. 5.2.1 Global Penicillin and Streptomycin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Penicillin and Streptomycin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Penicillin and Streptomycin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Penicillin and Streptomycin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Penicillin and Streptomycin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Penicillin and Streptomycin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Penicillin and Streptomycin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Penicillin and Streptomycin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical
  2. 6.1.1 Takeda Pharmaceutical Company Information
  3. 6.1.2 Takeda Pharmaceutical Business Overview
  4. 6.1.3 Takeda Pharmaceutical Penicillin and Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Penicillin and Streptomycin Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Penicillin and Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Penicillin and Streptomycin Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Penicillin and Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Penicillin and Streptomycin Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Eli Lilly
  20. 6.4.1 Eli Lilly Company Information
  21. 6.4.2 Eli Lilly Business Overview
  22. 6.4.3 Eli Lilly Penicillin and Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Eli Lilly Penicillin and Streptomycin Product Portfolio
  24. 6.4.5 Eli Lilly Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Penicillin and Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GlaxoSmithKline Penicillin and Streptomycin Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 Toyama Chemical
  32. 6.6.1 Toyama Chemical Company Information
  33. 6.6.2 Toyama Chemical Business Overview
  34. 6.6.3 Toyama Chemical Penicillin and Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Toyama Chemical Penicillin and Streptomycin Product Portfolio
  36. 6.6.5 Toyama Chemical Recent Developments
  37. 6.7 MiddleBrook Pharmaceuticals
  38. 6.7.1 MiddleBrook Pharmaceuticals Company Information
  39. 6.7.2 MiddleBrook Pharmaceuticals Business Overview
  40. 6.7.3 MiddleBrook Pharmaceuticals Penicillin and Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 MiddleBrook Pharmaceuticals Penicillin and Streptomycin Product Portfolio
  42. 6.7.5 MiddleBrook Pharmaceuticals Recent Developments
  43. 6.8 Gilead Sciences
  44. 6.8.1 Gilead Sciences Company Information
  45. 6.8.2 Gilead Sciences Business Overview
  46. 6.8.3 Gilead Sciences Penicillin and Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Gilead Sciences Penicillin and Streptomycin Product Portfolio
  48. 6.8.5 Gilead Sciences Recent Developments
  49. 6.9 Astra Zeneca
  50. 6.9.1 Astra Zeneca Company Information
  51. 6.9.2 Astra Zeneca Business Overview
  52. 6.9.3 Astra Zeneca Penicillin and Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Astra Zeneca Penicillin and Streptomycin Product Portfolio
  54. 6.9.5 Astra Zeneca Recent Developments
  55. 6.10 Astellas Pharma
  56. 6.10.1 Astellas Pharma Company Information
  57. 6.10.2 Astellas Pharma Business Overview
  58. 6.10.3 Astellas Pharma Penicillin and Streptomycin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Astellas Pharma Penicillin and Streptomycin Product Portfolio
  60. 6.10.5 Astellas Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Penicillin and Streptomycin Sales by Country
  2. 7.1.1 North America Penicillin and Streptomycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Penicillin and Streptomycin Sales by Country (2021-2026)
  4. 7.1.3 North America Penicillin and Streptomycin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Penicillin and Streptomycin Market Size by Country
  6. 7.2.1 North America Penicillin and Streptomycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Penicillin and Streptomycin Market Size by Country (2021-2026)
  8. 7.2.3 North America Penicillin and Streptomycin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Penicillin and Streptomycin Sales by Country
  2. 8.1.1 Europe Penicillin and Streptomycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Penicillin and Streptomycin Sales by Country (2021-2026)
  4. 8.1.3 Europe Penicillin and Streptomycin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Penicillin and Streptomycin Market Size by Country
  6. 8.2.1 Europe Penicillin and Streptomycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Penicillin and Streptomycin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Penicillin and Streptomycin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Penicillin and Streptomycin Sales by Country
  2. 9.1.1 Asia-Pacific Penicillin and Streptomycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Penicillin and Streptomycin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Penicillin and Streptomycin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Penicillin and Streptomycin Market Size by Country
  6. 9.2.1 Asia-Pacific Penicillin and Streptomycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Penicillin and Streptomycin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Penicillin and Streptomycin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Penicillin and Streptomycin Sales by Country
  2. 10.1.1 South America Penicillin and Streptomycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Penicillin and Streptomycin Sales by Country (2021-2026)
  4. 10.1.3 South America Penicillin and Streptomycin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Penicillin and Streptomycin Market Size by Country
  6. 10.2.1 South America Penicillin and Streptomycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Penicillin and Streptomycin Market Size by Country (2021-2026)
  8. 10.2.3 South America Penicillin and Streptomycin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Penicillin and Streptomycin Sales by Country
  2. 11.1.1 Middle East and Africa Penicillin and Streptomycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Penicillin and Streptomycin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Penicillin and Streptomycin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Penicillin and Streptomycin Market Size by Country
  6. 11.2.1 Middle East and Africa Penicillin and Streptomycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Penicillin and Streptomycin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Penicillin and Streptomycin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Penicillin and Streptomycin Value Chain Analysis
  2. 12.1.1 Penicillin and Streptomycin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Penicillin and Streptomycin Production Mode & Process
  7. 12.2 Penicillin and Streptomycin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Penicillin and Streptomycin Distributors
  10. 12.2.3 Penicillin and Streptomycin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst